Concentric Analgesics Data Unveils Extended Pain Relief and Reduced Opioid Use
Concentric Analgesics, a biotechnology company, announced the presentation of clinical data for their drug vocacapsaicin at the International Association...
Adaptive Clinical Trial Design Adaptive Trial Design Addiction Psychiatry AI in Clinical Trials Alzheimer's Disease Article Artificial Intelligence in Clinical Trials Clinical Operations Clinical Research Clinical Trial Design Clinical Trial Operations Clinical Trial Ops Brief Clinical Trials CLINOPS WATCHDOG CNS Drug Development CNS Trials Conference Coverage Decentralized Clinical Trials Digital Health Technologies dual diagnosis eClinical Tech News eClinical Technology EMA Executive Interviews FDA Enforcement FDA Guidance FDA Real-World Evidence FDA Regulation FDA Regulatory Strategy FDA Warning Letter GCP Compliance GLP-1 Receptor Agonists Ketamine Therapy Oncology Trials Opinion Parkinson's Disease Platform Trials Psilocybin MDMA Psychedelic Clinical Trials PSYCH PULSE Real-World Evidence site activation Site Operations study startup Treatment-Resistant Depression
Concentric Analgesics, a biotechnology company, announced the presentation of clinical data for their drug vocacapsaicin at the International Association...
In the realm of clinical trials, protecting participants’ personal data is paramount. The General Data Protection Regulation (GDPR), which...
In a fascinating session, “Applying Machine Learning and Artificial Intelligence for Predicting Product Profile Approvability” session, industry leaders dissected...
Lantern Pharma’s ongoing HARMONIC™ clinical trial has yielded promising early results. The trial examines the efficacy of LP-300, a...
We had the chance to sit down with Harven DeShield, Chief Executive Officer and Co-founder of Vivacelle Bio. We...
COYA 301, a recombinant human low-dose interleukin-2 (LD IL-2), and Glucagon-Like Peptide-1 receptor agonists (GLP-1 RAs) have demonstrated potential...
SanBio Co. Ltd has received approval in Japan for “AKUUGO® Suspension for Intracranial Implantation,” a groundbreaking cell-based therapy for...
The FDA has granted approval for Jemperli (dostarlimab-gxly) in combination with chemotherapy (carboplatin and paclitaxel) followed by Jemperli alone...
BostonGene and Takeda collaborate on research studies focused on immuno-oncology. Their partnership aims to enhance clinical trial design, improve...
The 2024 DIA conference session on decentralized clinical trials (DCTs) brought together leading experts from various sectors to discuss...